Related Experiment Videos
Decreased prostaglandin E turnover in infants with essential fatty acid deficiency
Insights
Essential fatty acid (EFA) deficiency in sick low birth weight infants (LBWI) is linked to lower prostaglandin (PG) levels. Supplementation rapidly corrects these deficiencies and restores PG excretion.
Area of Science:
- Biochemistry
- Neonatology
- Nutritional Science
Background:
- Sick low birth weight infants (LBWI) are susceptible to essential fatty acid (EFA) deficiency.
- EFAs are crucial precursors for prostaglandins (PGs), vital signaling molecules.
- Urinary prostaglandin metabolite (PGE-M) excretion reflects PG synthesis and EFA status.
Observation:
- PGE-M excretion was measured in EFA-deficient and thriving neonates.
- No significant differences in PGE-M excretion were observed based on sex or postconceptual age in thriving infants.
- EFA-deficient infants exhibited significantly lower PGE-M excretion compared to controls.
Findings:
- A significant increase in PGE-M excretion was observed in EFA-deficient infants after EFA treatment.
- The severity of EFA deficiency directly correlated with the degree of PG excretion.
- Biochemical markers of EFA deficiency and reduced PGE-M levels were rapidly reversed with EFA reintroduction.
Implications:
- Assessing PGE-M excretion can help diagnose and monitor EFA deficiency in LBWI.
- Maintaining adequate EFA levels is critical for prostaglandin synthesis and infant health.
- Dietary EFA supplementation is an effective therapeutic strategy for correcting EFA deficiency in neonates.
Abstract:
Sick low birth weight infants (LBWI) are prone to develop rapid onset of essential fatty acid (EFA) deficiency. EFAs serve as precursors for prostaglandins (PGs). We measured the excretion of the major urinary metabolite of prostaglandins E1 and E2, 7alpha-hydroxy-5,11-diketotetranorprostane-1,16-dionic acid (PGE-M), in three EFA-deficient and in nine thriving neonates. There was no significant difference in PGE-M excretion between the sexes among thriving infants nor did PGE-M excretion appear to be affected by postconceptual age. However, a significant difference between the PGE-M excretion in the group of infants with EFA deficiency before and after treatment is apparent (P less than 0.05). Significant differences in PGE-M excretion were also found between the control group and the EFA-deficient infants. The severity of the EFA deficiency correlates directly with the degree of PGs excretion. The biochemical evidences of EFA deficiency and the decreased levels of PGE-M excretion are rapidly corrected when patients resume a diet containing EFA.